ARTLVSMRNA• 12 Months (Normalized)
ARTL vs MRNA (Artelo Biosciences Inc. vs Moderna Inc.)
Showing Closing Date Range from Sep 30, 2025 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
-96.34%
Artelo Biosciences Inc.
Normalized Baseline0.00%
MRNA Performance $182.11
+%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
-96.34 pts
MRNA outperforming by 96.34 percentage points
ARTLMRNA
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(249 dates)
| Date | ARTL Price | ARTL Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $4.54 | -96.34% | $- | - | |
| Sep 24, 2026 | $5.17 | -95.83% | $- | - | |
| Sep 23, 2026 | $7.31 | -94.10% | $182.11 | +605.03% | -699.13% |
| Sep 22, 2026 | $4.15 | -96.65% | $182.56 | +606.78% | -703.43% |
| Sep 21, 2026 | $4.10 | -96.69% | $172.94 | +569.53% | -666.22% |
| Sep 18, 2026 | $3.94 | -96.82% | $154.04 | +496.36% | -593.18% |
| Sep 17, 2026 | $3.97 | -96.80% | $158.07 | +511.96% | -608.76% |
| Sep 16, 2026 | $3.75 | -96.97% | $145.62 | +463.76% | -560.73% |
| Sep 15, 2026 | $5.34 | -95.69% | $143.77 | +456.60% | -552.29% |
| Sep 14, 2026 | $4.87 | -96.07% | $146.69 | +467.91% | -563.98% |
| Sep 11, 2026 | $5.43 | -95.62% | $143.97 | +457.38% | -553.00% |
| Sep 10, 2026 | $5.63 | -95.46% | $136.62 | +428.92% | -524.38% |
| Sep 09, 2026 | $5.98 | -95.17% | $135.61 | +425.01% | -520.18% |
| Sep 08, 2026 | $6.19 | -95.01% | $140.33 | +443.28% | -538.29% |
| Sep 04, 2026 | $6.04 | -95.13% | $145.55 | +463.49% | -558.62% |
Page 1 of 17